Specialist life sciences fund Merchant Group raised its ownership in Rhythm Biosciences Ltd. to 7.01% from 5.02%.
Merchant made its initial investment in the Australia-based medical diagnostics company June 12.
Merchant Group increases stake in Rhythm Biosciences
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Merchant Group increases stake in Rhythm Biosciences
- Author Vince Iral
- Theme Healthcare & Pharmaceuticals
- Author
- Vince Iral
- Theme
- Healthcare & Pharmaceuticals